封面
市场调查报告书
商品编码
1741385

细胞外基质市场:按成分类型、按应用、按原材料、按最终用户、按产品类型、按技术、按治疗领域、按功能、按生物材料类型、按最终用途行业、按地区

Extracellular Matrix Market, By Component Type, By Application, By Source, By End-User, By Product Type, By Technology, By Therapeutic Area, By Function, By Biomaterial Type, By End-Use Industry, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 145 Pages | 商品交期: 2-3个工作天内

价格
简介目录

细胞外基质市场规模预计在 2025 年为 4,420 万美元,预计到 2032 年将达到 7,480 万美元,2025 年至 2032 年的复合年增长率为 7.8%。

分析范围 分析详细信息
基准年 2024 市场规模(2025年) 4420万美元
效能数据 2020-2024 预测期 2025-2032
预测期内的复合年增长率(2025-2032) 7.80% 预计金额(2032年) 7480万美元

细胞外基材(ECM) 是由蛋白质和碳水化合物组成的复杂网络,为组织和器官内的细胞提供结构支撑。它在调节细胞行为(包括细胞黏附、迁移、增殖和分化)中起着关键作用。 ECM 也充当生长因子和细胞因子的储存器,这些因子和细胞激素会影响各种细胞过程。

全球细胞外基质市场正经历显着成长,这得益于慢性病盛行率的上升、再生医学需求的不断增长以及组织工程技术的进步。人口老化加剧,导致心血管疾病、整形外科疾病、皮肤溃疡等慢性疾病的发生,是推动市场成长的主要因素。此外,外科手术数量的增加以及对有效创伤治疗解决方案的需求也推动了对细胞外基质产品的需求。

然而,市场面临基于 ECM 的治疗方法价格高昂、监管要求严格、报销政策限制等挑战。此外,医疗保健专业人员和患者对基于 ECM 的产品益处缺乏认识,阻碍了市场成长。

然而,市场提供了多种成长机会,例如开发基于 ECM 的创新产品、与学术和工业参与者的合作、扩大新兴市场的产品系列等。此外,对个人化医疗的日益关注以及 ECM 技术与其他先进疗法的整合为市场扩张提供了光明的前景。

总而言之,受慢性病发病率上升和再生药物需求成长的推动,全球细胞外基质市场预计将在未来几年大幅成长。然而,要充分发挥市场潜力,仍需应对高成本和认知度不足等挑战。

市场动态:

全球细胞外基质市场受多种因素驱动,包括慢性病的流行、组织工程的进步以及再生医学需求的不断增长。日益增长的老龄化人口易患慢性病,这是市场成长的主要驱动力。此外,外科手术数量的增加以及对有效创伤治疗解决方案的需求也推动了对细胞外基质产品的需求。

然而,市场面临许多挑战,例如基于ECM的疗法高成本、监管要求严格以及报销政策限制。基于ECM的疗法成本高昂,限制了其覆盖更广泛的患者群体,成为市场成长的主要障碍。此外,ECM产品核准的严格监管要求以及部分地区有限的报销政策也阻碍了市场扩张。

儘管面临诸多挑战,市场仍蕴含着许多成长机会。生物活性支架和组织工程构建体等创新细胞外基质 (ECM) 产品的开发,蕴含着巨大的市场拓展潜力。学术机构与产业参与者之间的合作可以进一步促进创新,加速先进细胞外基质 (ECM) 技术的发展。此外,随着再生医学需求的不断增长,新兴市场产品系列的拓展,也能为市场成长开闢新的途径。

总而言之,全球细胞外基质市场受到慢性病的流行和再生药物需求的不断增长等因素的驱动。然而,高成本和监管要求等挑战亟待解决,同时,技术创新和新兴地区市场扩张等机会也亟待把握。

本报告的主要特点

  • 本报告对全球细胞外基质市场进行了详细分析,并以 2024 年为基准年,展示了预测期(2025-2032)的市场规模和复合年增长率。
  • 它还强调了每个细分市场的潜在商机,并解释了该市场的有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素和机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
  • 透过本报告的见解,负责人和企业经营团队可以就未来的产品发布、合作伙伴关係、市场扩张和行销策略做出明智的决策。
  • 「全球细胞外基质市场」报告涉及该行业的各个相关人员,包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
  • 相关人员可以透过用于分析全球细胞外基质市场的各种策略矩阵来更轻鬆地做出决策。

目录

第一章 分析目标与前提条件

  • 分析目的
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map (COM)

第三章市场动态、法规与趋势分析

  • 市场动态
    • 驱动程式
      • 慢性病增多
    • 限制因素
      • 基于ECM的治疗方法高成本
    • 机会
      • 开发基于 ECM 的创新产品
  • 影响分析
  • 主要亮点
  • 监管情景
  • 产品发布/核准
  • PEST分析
  • 波特五力分析
  • 企业合併(M&A)场景

4. 全球细胞外基质市场:COVID-19感染疾病的影响

  • COVID-19流行病学
  • 供需侧分析
  • 经济影响

5. 全球细胞外基质市场依成分类型划分(2020-2032)

  • 蛋白质
  • 糖蛋白
  • 蛋白多醣
  • 其他 ECM 分子

6. 全球细胞外基质市场应用(2020-2032)

  • 再生医学
  • 组织工程
  • 创伤治疗
  • 药物输送
  • 癌症研究
  • 其他的

7. 全球细胞外基质市场依来源划分(2020-2032)

  • 动物源性ECM
  • 人源性ECM
  • 合成ECM

8. 全球细胞外基质市场(依最终用户划分)(2020-2032)

  • 研究机构和学术中心
  • 生物技术和製药公司
  • 医院和诊所

9. 全球细胞外基质市场依产品类型(2020-2032)

  • 水凝胶
  • 鹰架
  • 去细胞ECM
  • ECM模拟
  • 其他的

10. 全球细胞外基质市场(依技术划分)(2020-2032)

  • 3D生物列印
  • 奈米科技
  • 细胞培养技术
  • 基因工程
  • 其他的

第 11 章 依治疗领域分類的全球细胞外基质市场(2020-2032 年)

  • 整形外科
  • 皮肤科
  • 心臟病学
  • 神经病学
  • 肿瘤学
  • 其他的

第 12 章 全球细胞外基质市场(依功能划分)(2020-2032 年)

  • 结构支撑
  • 行动电话通讯
  • 细胞黏附
  • 讯号传导

第 13 章。按生物材料类型分類的全球细胞外基质市场(2020-2032 年)

  • 天然ECM
  • 合成ECM

14. 全球细胞外基质市场依最终用途产业划分(2020-2032)

  • 医疗保健
  • 研究与开发
  • 化妆品
  • 製药
  • 其他的

第 15 章全球细胞外基质市场(按地区)(2020-2032 年)

  • 北美洲
      • 美国
      • 加拿大
  • 欧洲
      • 英国
      • 德国
      • 义大利
      • 法国
      • 西班牙
      • 俄罗斯
      • 其他欧洲国家
  • 亚太地区
      • 中国
      • 印度
      • 日本
      • ASEAN
      • 澳洲
      • 韩国
      • 其他亚太地区
  • 拉丁美洲
      • 巴西
      • 墨西哥
      • 阿根廷
      • 其他拉丁美洲
  • 中东
      • GCC
      • 以色列
      • 其他中东地区
  • 非洲
      • 北非
      • 中部非洲
      • 南非

第十六章竞争格局

  • Thermo Fisher Scientific
  • DSM
  • Acelity(KCI Concepts)
  • Corning Incorporated
  • Baxter
  • FUJIFILM Holdings Corporation
  • Integra LifeSciences
  • CellSystems Biotechnologie Vertrieb GmbH
  • Biotime, Inc.
  • Trevigen, Inc.
  • Advanced BioMatrix
  • Collagen Matrix, Inc.
  • Merck KGaA
  • VWR International LLC
  • REPROCELL USA Inc.
  • BioLamina AB
  • Matricel GmbH
  • Tissue Regenix
  • Admedus
  • MIMETAS

第 17 章 章节

  • 分析方法
  • 关于出版商
简介目录
Product Code: CMI6171

Extracellular Matrix Market is estimated to be valued at USD 44.2 Mn in 2025 and is expected to reach USD 74.8 Mn by 2032, growing at a compound annual growth rate (CAGR) of 7.8% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 44.2 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 7.80% 2032 Value Projection: USD 74.8 Mn

Extracellular matrix (ECM) refers to the complex network of proteins and carbohydrates that provide structural support to cells within tissues and organs. It plays a crucial role in regulating cell behavior, including cell adhesion, migration, proliferation, and differentiation. The ECM also acts as a reservoir for growth factors and cytokines, influencing various cellular processes.

The global extracellular matrix market is witnessing significant growth due to the increasing prevalence of chronic diseases, rising demand for regenerative medicine, and advancements in tissue engineering. The market is driven by the growing aging population, which is more susceptible to chronic conditions such as cardiovascular diseases, orthopedic disorders, and skin ulcers. Additionally, the rising number of surgical procedures and the need for effective wound healing solutions are fueling the demand for ECM products.

However, the market faces challenges such as the high cost of ECM-based therapies, stringent regulatory requirements, and limited reimbursement policies. Moreover, the lack of awareness among healthcare professionals and patients about the benefits of ECM-based products hinders market growth.

Nevertheless, the market presents several opportunities for growth, including the development of innovative ECM-based products, collaborations between academic institutions and industry players, and the expansion of product portfolios in emerging markets. Furthermore, the increasing focus on personalized medicine and the integration of ECM technologies with other advanced therapies offer promising prospects for market expansion.

In conclusion, the global extracellular matrix market is poised for significant growth in the coming years, driven by the increasing prevalence of chronic diseases and the growing demand for regenerative medicine. However, challenges such as high costs and limited awareness need to be addressed to fully realize the market's potential.

Market Dynamics:

The global extracellular matrix market is driven by several factors, including the increasing prevalence of chronic diseases, advancements in tissue engineering, and the rising demand for regenerative medicine. The growing aging population, which is more susceptible to chronic conditions, is a key driver for market growth. Additionally, the rising number of surgical procedures and the need for effective wound healing solutions are fueling the demand for extracellular matrix products.

However, the market faces challenges such as the high cost of ECM-based therapies, stringent regulatory requirements, and limited reimbursement policies. The high cost of ECM-based therapies poses a significant barrier to market growth, limiting their accessibility to a larger patient population. Moreover, the stringent regulatory requirements for the approval of ECM-based products and the limited reimbursement policies in some regions hinder market expansion.

Despite these challenges, the market presents several opportunities for growth. The development of innovative ECM-based products, such as bioactive scaffolds and tissue-engineered constructs, holds immense potential for market expansion. Collaborations between academic institutions and industry players can further drive innovation and accelerate the development of advanced ECM technologies. Additionally, the expansion of product portfolios in emerging markets, where the demand for regenerative medicine is growing, can open up new avenues for market growth.

In conclusion, the global extracellular matrix market is driven by factors such as the increasing prevalence of chronic diseases and the rising demand for regenerative medicine. However, challenges such as high costs and regulatory requirements need to be addressed, while opportunities such as innovation and market expansion in emerging regions should be capitalized upon.

Key features of the study:

  • This report provides in-depth analysis of the global extracellular matrix market, including market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), with 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • Key companies covered as a part of this study include Thermo Fisher Scientific, DSM, Acelity (KCI Concepts), Corning Incorporated, Baxter, FUJIFILM Holdings Corporation, Integra LifeSciences, CellSystems Biotechnologie Vertrieb GmbH, Biotime, Inc., Trevigen, Inc., Advanced BioMatrix, Collagen Matrix, Inc., Merck KGaA, VWR International LLC, REPROCELL USA Inc., BioLamina AB, Matricel GmbH, Tissue Regenix, Admedus, and MIMETAS.
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding their future product launches, type upgrades, market expansion, and marketing tactics.
  • The global extracellular matrix market report caters to various stakeholders in this industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global extracellular matrix market.

Detailed Segmentation:

  • Global Extracellular Matrix Market, By Component Type:
    • Proteins
    • Glycoproteins
    • Proteoglycans
    • Other ECM molecules
  • Global Extracellular Matrix Market, By Application:
    • Regenerative Medicine
    • Tissue Engineering
    • Wound Healing
    • Drug Delivery
    • Cancer Research
    • Others
  • Global Extracellular Matrix Market, By Source:
    • Animal-Derived ECM
    • Human-Derived ECM
    • Synthetic ECM
  • Global Extracellular Matrix Market, By End-User:
    • Research Institutes and Academic Centers
    • Biotechnology and Pharmaceutical Companies
    • Hospitals and Clinics
  • Global Extracellular Matrix Market, By Product Type:
    • Hydrogels
    • Scaffolds
    • Decellularized ECM
    • ECM Analogs
    • Others
  • Global Extracellular Matrix Market, By Technology:
    • 3D Bioprinting
    • Nanotechnology
    • Cell Culture Techniques
    • Genetic Engineering
    • Others
  • Global Extracellular Matrix Market, By Therapeutic Area:
    • Orthopedics
    • Dermatology
    • Cardiology
    • Neurology
    • Oncology
    • Others
  • Global Extracellular Matrix Market, By Function:
    • Structural Support
    • Cellular Communication
    • Cell Adhesion
    • Signal Transduction
  • Global Extracellular Matrix Market, By Biomaterial Type:
    • Natural ECM
    • Synthetic ECM
  • Global Extracellular Matrix Market, By End-Use Industry:
    • Healthcare
    • Research and Development
    • Cosmetics
    • Pharmaceuticals
    • Others
  • Global Extracellular Matrix Market, By By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa
  • Company Profiles:
    • Thermo Fisher Scientific
    • DSM
    • Acelity (KCI Concepts)
    • Corning Incorporated
    • Baxter
    • FUJIFILM Holdings Corporation
    • Integra LifeSciences
    • CellSystems Biotechnologie Vertrieb GmbH
    • Biotime, Inc.
    • Trevigen, Inc.
    • Advanced BioMatrix
    • Collagen Matrix, Inc.
    • Merck KGaA
    • VWR International LLC
    • REPROCELL USA Inc.
    • BioLamina AB
    • Matricel GmbH
    • Tissue Regenix
    • Admedus
    • MIMETAS

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Global Extracellular Matrix, By Component Type
    • Market Global Extracellular Matrix, By Application
    • Market Global Extracellular Matrix, By Source
    • Market Global Extracellular Matrix, By End-User
    • Market Global Extracellular Matrix, By Product Type
    • Market Global Extracellular Matrix, By Technology
    • Market Global Extracellular Matrix, By Therapeutic Area
    • Market Global Extracellular Matrix, By Function
    • Market Global Extracellular Matrix, By Biomaterial Type
    • Market Global Extracellular Matrix, By End-Use Industry
    • Market Global Extracellular Matrix, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • The increasing prevalence of chronic diseases
    • Restraints
  • High cost of ECM-based therapies
    • Opportunities
  • Development of innovative ECM-based products
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Extracellular Matrix Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Extracellular Matrix Market, By Component Type, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Proteins
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Glycoproteins
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Proteoglycans
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Other ECM molecules
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Global Extracellular Matrix Market, By Application, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Regenerative Medicine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Tissue Engineering
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Wound Healing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Drug Delivery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Cancer Research
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Global Extracellular Matrix Market, By Source, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Animal-Derived ECM
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Human-Derived ECM
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Synthetic ECM
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

8. Global Extracellular Matrix Market, By End-User, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Research Institutes and Academic Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Biotechnology and Pharmaceutical Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Hospitals and Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

9. Global Extracellular Matrix Market, By Product Type, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hydrogels
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Scaffolds
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Decellularized ECM
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • ECM Analogs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

10. Global Extracellular Matrix Market, By Technology, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • 3D Bioprinting
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Nanotechnology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Cell Culture Techniques
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Genetic Engineering
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

11. Global Extracellular Matrix Market, By Therapeutic Area, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Orthopedics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Dermatology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Cardiology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Neurology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

12. Global Extracellular Matrix Market, By Function, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Structural Support
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Cellular Communication
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Cell Adhesion
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Signal Transduction
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

13. Global Extracellular Matrix Market, By Biomaterial Type, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Natural ECM
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Synthetic ECM
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

14. Global Extracellular Matrix Market, By End-Use Industry, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Healthcare
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Research and Development
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Cosmetics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Pharmaceuticals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

15. Global Extracellular Matrix Market, By Region, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Country, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Country 2021-2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End-User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Function, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Biomaterial Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End-Use Industry, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End-User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Function, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Biomaterial Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End-Use Industry, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End-User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Function, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Biomaterial Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End-Use Industry, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End-User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Function, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Biomaterial Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End-Use Industry, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End-User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Function, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Biomaterial Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End-Use Industry, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End-User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Function, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Biomaterial Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End-Use Industry, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • North Africa
      • Central Africa
      • South Africa

16. Competitive Landscape

  • Thermo Fisher Scientific
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • DSM
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Acelity (KCI Concepts)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Corning Incorporated
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Baxter
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • FUJIFILM Holdings Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Integra LifeSciences
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • CellSystems Biotechnologie Vertrieb GmbH
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Biotime, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Trevigen, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Advanced BioMatrix
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Collagen Matrix, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Merck KGaA
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • VWR International LLC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • REPROCELL USA Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • BioLamina AB
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Matricel GmbH
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Tissue Regenix
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Admedus
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • MIMETAS
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

17. Section

  • Research Methodology
  • About us